全球吸入麻醉剂市场规模、份额、趋势和成长分析报告（2026-2034年）

预计吸入麻醉剂市场将从 2025 年的 24.1 亿美元成长到 2034 年的 55 亿美元，2026 年至 2034 年的复合年增长率为 9.59%。

随着外科手术技术的日益精进和普及，吸入麻醉剂的全球市场也随之成长。吸入麻醉剂透过呼吸系统给药，用于诱导和维持手术期间的无意识状态。这些麻醉剂常用于医院和手术中心需要全身麻醉的手术。

全球手术数量的增加和医疗基础设施的扩大是推动市场成长的主要因素。吸入式麻醉剂起效迅速，镇静作用可控，因此适用于多种医疗程序。此外，麻醉给药系统和病患监测技术的进步也提高了其安全性和有效性。

随着外科技术和医疗服务的进步，吸入麻醉剂市场前景仍然光明。对新型麻醉剂配方的研究可望提高病患安全性和缩短復原时间。此外，发展中国家外科医疗服务的普及预计将推动需求成长。随着医疗保健系统的不断发展，吸入麻醉剂仍将是现代外科医疗的重要组成部分。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球吸入麻醉剂市场：依药物类型划分

• 市场分析、洞察与预测
• SEVOFLURANE
• DESFLURANE
• Isoflurane
• 其他的

第五章：全球吸入麻醉剂市场：依应用划分

• 市场分析、洞察与预测
• 介绍
• 维护和管理

第六章：全球吸入麻醉剂市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 其他的

第七章 全球吸入麻醉剂市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • AbbVie Inc
  • Baxter International Inc
  • Dechra Pharmaceuticals PLC（Halocarbon Life Sciences LLC）
  • Fresenius Kabi AG（Fresenius SE & Co. KGaA）
  • Hikma Pharmaceuticals PLC
  • Jiangsu Hengrui Medicine Co. Ltd
  • Lunan Pharmaceutical Group Co. Ltd
  • Merck KGaA
  • Piramal Enterprises Limited
  • Troikaa Pharmaceuticals Ltd

The Inhalation Anesthesia Market size is expected to reach USD 5.50 Billion in 2034 from USD 2.41 Billion (2025) growing at a CAGR of 9.59% during 2026-2034.

The global inhalation anesthesia market has grown as surgical procedures become more advanced and widely available. Inhalation anesthesia involves the use of anesthetic gases delivered through breathing systems to induce and maintain unconsciousness during surgery. These anesthetics are commonly used in hospitals and surgical centers for procedures requiring general anesthesia.

Market growth is driven by the increasing number of surgeries performed worldwide and the expansion of healthcare infrastructure. Inhalation anesthetics provide rapid onset and controlled sedation, making them suitable for various medical procedures. Improvements in anesthesia delivery systems and patient monitoring technologies have also enhanced safety and effectiveness.

The future outlook for the inhalation anesthesia market remains promising as surgical techniques and healthcare services continue to advance. Research into new anesthetic formulations may improve patient safety and recovery times. Expanding access to surgical care in developing regions is also expected to increase demand. As healthcare systems continue to grow, inhalation anesthesia will remain a critical component of modern surgical practice.

MARKET SEGMENTATION

By Drug

• Sevoflurane
• Desflurane
• Isoflurane
• Others

By Application

• Induction
• Maintenance

By End-Use

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• AbbVie Inc, Baxter International Inc, Dechra Pharmaceuticals PLC Halocarbon Life Sciences LLC, Fresenius Kabi AG Fresenius SE Co KGaA, Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co Ltd, Lunan Pharmaceutical Group Co Ltd, Merck KGaA, Piramal Enterprises Limited, Troikaa Pharmaceuticals Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INHALATION ANESTHESIA MARKET: BY DRUG 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug
• 4.2. Sevoflurane Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Desflurane Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Isoflurane Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INHALATION ANESTHESIA MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Induction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Maintenance Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INHALATION ANESTHESIA MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INHALATION ANESTHESIA MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Drug
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Drug
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Drug
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Drug
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Drug
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL INHALATION ANESTHESIA INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 AbbVie Inc
  • 9.2.2 Baxter International Inc
  • 9.2.3 Dechra Pharmaceuticals PLC (Halocarbon Life Sciences LLC)
  • 9.2.4 Fresenius Kabi AG (Fresenius SE & Co. KGaA)
  • 9.2.5 Hikma Pharmaceuticals PLC
  • 9.2.6 Jiangsu Hengrui Medicine Co. Ltd
  • 9.2.7 Lunan Pharmaceutical Group Co. Ltd
  • 9.2.8 Merck KGaA
  • 9.2.9 Piramal Enterprises Limited
  • 9.2.10 Troikaa Pharmaceuticals Ltd